Skip to main content
Premium Trial:

Request an Annual Quote

Swiss Lab Buys Partek's Genomics Lab for Epigenetic, Neurobio Studies

NEW YORK (GenomeWeb News) — The Friedrich Miescher Institute for Biomedical Research in Basel, Switzerland has bought Partek’s tiling and exon array data-handling software, Partek said yesterday.  
 
Partek said FMI’s Functional Genomics Lab will use its genomics suite software to analyze data from studies of epigenetics, growth control, and neurobiology.
 
Partek, based in St. Louis, Mo., is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform used to identify and quantify data patterns.
 
Partek said its genomics suite handles data from “genomic and proteomic studies, high throughput-screening campaigns, and computer-aided drug design.”
 
Financial terms of the deal were not released.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.